ELEV

Elevation Oncology
ELEV

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ELEV was delisted on the 22nd of July, 2025.

Back to rankings

36 hedge funds and large institutions have $217M invested in Elevation Oncology in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$38.5M
2
+$35.4M
3
+$26.5M
4
CAM
Cormorant Asset Management
Massachusetts
+$25.6M
5
BI
BVF Inc
California
+$21.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$38.5M
2
$35.4M
3
$26.5M
4
$25.6M
5
$21.6M
6
$18.2M
7
$13.6M
8
$12.7M
9
$6.74M
10
$1.9M
11
$1.7M
12
$1.7M
13
$1.67M
14
$1.53M
15
$1.36M
16
$1.36M
17
$1.09M
18
$848K
19
$814K
20
$814K
21
$679K
22
$537K
23
$494K
24
$425K
25
$407K
1
2